|
|
Post by porkini on Mar 15, 2019 8:54:14 GMT -5
Porkini...I like that. I hadn't thought of the pit crew as a place of sponsorship. "Fast in, Fast out" is essentially a huge piece of the entire mission for the pit crew. I didn't think of them as being the delivery part (dreamboat) and the car as the powder. The real value in the sponsorship isn't the Mannkind logo on the car or the driver's suit. The real value is in the special interest stories and interviews with the drivers. Unfortuantely few will recognize the Mannkind logo or the name Afrezza. The value comes when Conor is asked about the challenge of driving 500 miles wheel to wheel at a high rate of speed with diabetes. This will come up during qualifying interviews and pre and post race. Hopefully Conor will pull out a dream boat, give a demonstration and tell the viewers how Afrezza has changed his life. That's when PWDs, doctors and the general public will see an athelite competing under extreme pressure thrives using Afrezza to control his sugars. The broadcasters covering Indy love this kind of story to show the human side of racing. Garrett Ingram has finally taken the Afrezza story in good direction. Now it's up to Conor to tell his story. He won't be as entusiatic as Jake, but he should reach a large audience. Not arguing against what you said barnstormer just trying to see the bigger picture here. The real value is an anagram in the name, b Arns Tor MEr, and unfortunately it is TEAM. This car thingy, it is a TEAM effort, and hopefully, the sponsorship and branding visibility and messaging is carried throughout the entire TEAM. How appropriate that needles on speedometers can be a tie in for driver and fast in and fast out can be a tie in for the pit crew. The fact that Conor Daly uses the product and it allows him to continue his life normally and pursue his dreams and aspirations is a very big special interest story that hopefully gets to the light of day. That "few will recognize the Mannkind logo or the name Afrezza" at this point is not remotely surprising, this gives much needed visibility. Some folks were hoping for a major football spectacle ad, well, this is one of the "Super Bowl" events of auto racing that Mannkind is now a part of. I'm liking it.  |
|
|
|
Post by prcgorman2 on Mar 15, 2019 8:55:49 GMT -5
i think Garrett is handling corporate sponsorships. This isn't Conor's first insulin sponsors. Conor is also quoted as a "Dexcom Warrior" so I a sure she knows Conor. Garrett Ingram is the Chief Marketing Officer for MannKind Corporation. Garrett comes to MannKind with a significant depth of experience in the biopharmaceutical industry and in diabetes marketing and market access. Most recently, Garrett served as Senior Vice President, Managed Markets for Dexcom, where she was responsible for developing long-term health outcomes and market access strategy for their portfolio of products. Before joining Dexcom, Garrett served as U.S. Country Head of Market Access at Sanofi, where she was responsible for all market access activities across four U.S. Business Units: Diabetes & Cardiovascular, General Medicines, Sanofi Genzyme Specialty Care, and Sanofi Pasteur. Prior to this, she held the position of Vice President, Market Access Strategy at Bristol Myers Squibb (BMS), where she led the access, reimbursement, patient affordability and emerging customer strategy teams across the portfolio of diabetes, rheumatoid arthritis, cardiovascular, oncology, immunology, neuroscience, and pipeline assets. Prior to BMS, she held various leadership roles for the commercial and medical organizations at Novo Nordisk. You had me right up until you mentioned Sanofi. If Garrett was at Sanofi between 2014 and 2016, I would suspect a mole.
I was bitter at first about Sanofi stabbing Mannkind in the back [particularly with respect to lackluster marketing & sales, and reneging on trials and milestones], but I'm over it now. |
|
|
|
Post by mnkdfann on Mar 15, 2019 9:31:16 GMT -5
Not arguing against what you said barnstormer just trying to see the bigger picture here. The real value is an anagram in the name, bArnsTorMEr, and unfortunately it is TEAM. This car thingy, it is a TEAM effort, and hopefully, the sponsorship and branding visibility and messaging is carried throughout the entire TEAM. How appropriate that needles on speedometers can be a tie in for driver and fast in and fast out can be a tie in for the pit crew. The fact that Conor Daly uses the product and it allows him to continue his life normally and pursue his dreams and aspirations is a very big special interest story that hopefully gets to the light of day. That "few will recognize the Mannkind logo or the name Afrezza" at this point is not remotely surprising, this gives much needed visibility. Some folks were hoping for a major football spectacle ad, well, this is one of the "Super Bowl" events of auto racing that Mannkind is now a part of. I'm liking it. Where does that 'fact' come from? Source, please. Every article I can find in which he describes his regimen, he involves a mention of using needles / shots / injections. Never a mention of inhaling insulin (that I've seen). www.upi.com/Sports_News/2018/08/17/Diabetic-drivers-defied-medical-advice-flourish-in-IndyCar-NASCAR/2731534435260/Ryan Reed and Conor Daly compete at racing's highest levels, all the while combating diabetes. Among the cluster of car-related gauges, the drivers monitor their glucose levels to make sure that they maintain their health and don't lose control. Although neither driver has ever had a close call or needed an insulin injection during a race, their pit crews are prepared to provide it should the need arise. youarecurrent.com/2016/05/17/road-runner-type-1-diabetes-hasnt-slowed-racer-conor-daly-on-the-path-to-his-dream/On race days, Daly follows a dedicated regiment of eating the correct diet at proper times and taking his insulin shots. He wears a glucose monitoring system, and there is also one his racecar. “Every race I have done so far this year, my blood sugar hasn’t changed at all,” he said. “There is so much adrenaline that it overrules every other problem your body has. It just takes control.” |
|
|
|
Post by porkini on Mar 15, 2019 9:39:42 GMT -5
Not arguing against what you said barnstormer just trying to see the bigger picture here. The real value is an anagram in the name, bArnsTorMEr, and unfortunately it is TEAM. This car thingy, it is a TEAM effort, and hopefully, the sponsorship and branding visibility and messaging is carried throughout the entire TEAM. How appropriate that needles on speedometers can be a tie in for driver and fast in and fast out can be a tie in for the pit crew. The fact that Conor Daly uses the product and it allows him to continue his life normally and pursue his dreams and aspirations is a very big special interest story that hopefully gets to the light of day. That "few will recognize the Mannkind logo or the name Afrezza" at this point is not remotely surprising, this gives much needed visibility. Some folks were hoping for a major football spectacle ad, well, this is one of the "Super Bowl" events of auto racing that Mannkind is now a part of. I'm liking it. Where does that 'fact' come from? Source, please. Just trying to help you keep up fann - mnkd.proboards.com/post/173399/thread |
|
|
|
Post by mnkdfann on Mar 15, 2019 9:44:52 GMT -5
Well, then that's great. Hope he starts mentioning that fact soon in articles and interviews. |
|
|
|
Post by porkini on Mar 15, 2019 10:51:42 GMT -5
Not arguing against what you said barnstormer just trying to see the bigger picture here. The real value is an anagram in the name, bArnsTorMEr, and unfortunately it is TEAM. This car thingy, it is a TEAM effort, and hopefully, the sponsorship and branding visibility and messaging is carried throughout the entire TEAM. How appropriate that needles on speedometers can be a tie in for driver and fast in and fast out can be a tie in for the pit crew. The fact that Conor Daly uses the product and it allows him to continue his life normally and pursue his dreams and aspirations is a very big special interest story that hopefully gets to the light of day. That "few will recognize the Mannkind logo or the name Afrezza" at this point is not remotely surprising, this gives much needed visibility. Some folks were hoping for a major football spectacle ad, well, this is one of the "Super Bowl" events of auto racing that Mannkind is now a part of. I'm liking it. Where does that 'fact' come from? Source, please. Every article I can find in which he describes his regimen, he involves a mention of using needles / shots / injections. Never a mention of inhaling insulin (that I've seen). www.upi.com/Sports_News/2018/08/17/Diabetic-drivers-defied-medical-advice-flourish-in-IndyCar-NASCAR/2731534435260/Ryan Reed and Conor Daly compete at racing's highest levels, all the while combating diabetes. Among the cluster of car-related gauges, the drivers monitor their glucose levels to make sure that they maintain their health and don't lose control. Although neither driver has ever had a close call or needed an insulin injection during a race, their pit crews are prepared to provide it should the need arise. youarecurrent.com/2016/05/17/road-runner-type-1-diabetes-hasnt-slowed-racer-conor-daly-on-the-path-to-his-dream/On race days, Daly follows a dedicated regiment of eating the correct diet at proper times and taking his insulin shots. He wears a glucose monitoring system, and there is also one his racecar. “Every race I have done so far this year, my blood sugar hasn’t changed at all,” he said. “There is so much adrenaline that it overrules every other problem your body has. It just takes control.” And the references pulled are from 2016 and August 2018 (right around the time Lilly pulled their support). Again - mnkd.proboards.com/post/173399/thread - how about we find out from him when he started on Afrezza? Maybe that is something that will come out in the special interest story. |
|
|
|
Post by rockstarrick on Mar 15, 2019 11:46:18 GMT -5
i think Garrett is handling corporate sponsorships. This isn't Conor's first insulin sponsors. Conor is also quoted as a "Dexcom Warrior" so I a sure she knows Conor. Garrett Ingram is the Chief Marketing Officer for MannKind Corporation. Garrett comes to MannKind with a significant depth of experience in the biopharmaceutical industry and in diabetes marketing and market access. Most recently, Garrett served as Senior Vice President, Managed Markets for Dexcom, where she was responsible for developing long-term health outcomes and market access strategy for their portfolio of products. Before joining Dexcom, Garrett served as U.S. Country Head of Market Access at Sanofi, where she was responsible for all market access activities across four U.S. Business Units: Diabetes & Cardiovascular, General Medicines, Sanofi Genzyme Specialty Care, and Sanofi Pasteur. Prior to this, she held the position of Vice President, Market Access Strategy at Bristol Myers Squibb (BMS), where she led the access, reimbursement, patient affordability and emerging customer strategy teams across the portfolio of diabetes, rheumatoid arthritis, cardiovascular, oncology, immunology, neuroscience, and pipeline assets. Prior to BMS, she held various leadership roles for the commercial and medical organizations at Novo Nordisk. You had me right up until you mentioned Sanofi. If Garrett was at Sanofi between 2014 and 2016, I would suspect a mole.
I was bitter at first about Sanofi stabbing Mannkind in the back [particularly with respect to lackluster marketing & sales, and reneging on trials and milestones], but I'm over it now. Sanofi flat out lied to PWD !! I remember several people contacting Sanofi/Canada asking about Afrezza, and when they could expect to see it in Canada. Sanofi blatantly lied to them via Twitter, I called them out on it. It’s one thing to string Mannkind and it’s investors along, but to lie to people with Diabetes, who are counting on being able to try something new, and obviously better than their current options, is pretty sick IMO. I realize there is a lot of space between the people calling the shots, and the person responding to Customers tweets about a new drug, but the correspondence between Sny and the people asking about Afrezza in Canada, was maybe a week before Sny announced they were pulling the plug on Afrezza. And then have your reps out there telling Healthcare Providers that Afrezza was basically dead 💀. Sanofi, the Company, had bad intentions for Afrezza from day 1. Someone should be sitting behind bars. Makes me sick to just think about those days. ✌🏻😎 |
|
|
|
Post by sportsrancho on Mar 15, 2019 12:00:06 GMT -5
Not arguing against what you said barnstormer just trying to see the bigger picture here. The real value is an anagram in the name, bArnsTorMEr, and unfortunately it is TEAM. This car thingy, it is a TEAM effort, and hopefully, the sponsorship and branding visibility and messaging is carried throughout the entire TEAM. How appropriate that needles on speedometers can be a tie in for driver and fast in and fast out can be a tie in for the pit crew. The fact that Conor Daly uses the product and it allows him to continue his life normally and pursue his dreams and aspirations is a very big special interest story that hopefully gets to the light of day. That "few will recognize the Mannkind logo or the name Afrezza" at this point is not remotely surprising, this gives much needed visibility. Some folks were hoping for a major football spectacle ad, well, this is one of the "Super Bowl" events of auto racing that Mannkind is now a part of. I'm liking it. Where does that 'fact' come from? Source, please. Every article I can find in which he describes his regimen, he involves a mention of using needles / shots / injections. Never a mention of inhaling insulin (that I've seen). www.upi.com/Sports_News/2018/08/17/Diabetic-drivers-defied-medical-advice-flourish-in-IndyCar-NASCAR/2731534435260/Ryan Reed and Conor Daly compete at racing's highest levels, all the while combating diabetes. Among the cluster of car-related gauges, the drivers monitor their glucose levels to make sure that they maintain their health and don't lose control. Although neither driver has ever had a close call or needed an insulin injection during a race, their pit crews are prepared to provide it should the need arise. youarecurrent.com/2016/05/17/road-runner-type-1-diabetes-hasnt-slowed-racer-conor-daly-on-the-path-to-his-dream/On race days, Daly follows a dedicated regiment of eating the correct diet at proper times and taking his insulin shots. He wears a glucose monitoring system, and there is also one his racecar. “Every race I have done so far this year, my blood sugar hasn’t changed at all,” he said. “There is so much adrenaline that it overrules every other problem your body has. It just takes control.” |
|
|
|
Post by mannmade on Mar 15, 2019 12:20:40 GMT -5
Perhaps he is only using for corrections at the moment.
|
|
|
|
Post by sportsrancho on Mar 15, 2019 12:57:11 GMT -5
Perhaps he is only using for corrections at the moment. No🤦🏼♀️ |
|
|
|
Post by longliner on Mar 15, 2019 13:31:06 GMT -5
With the addition of a strong user / advocate that represents the Afrezza profile, (fast) the shrill voices will continue to grow as they watch their fortunes reverse since December 27 and into 2019.
|
|
|
|
Post by Omega on Mar 15, 2019 13:41:53 GMT -5
THIS IS FANTASTIC NEWS! He confirmed he actually uses Afrezza. |
|
|
|
Post by itellthefuture777 on Mar 15, 2019 21:12:56 GMT -5
|
|
|
|
Post by nylefty on Mar 15, 2019 21:43:12 GMT -5
Not a word about Afrezza! Not good. |
|
|
|
Post by sweedee79 on Mar 15, 2019 23:51:07 GMT -5
Not a word about Afrezza! Not good. "Thanks to MannKind I will be able to share my story and live my dream at a higher level than ever.”. Conner Daly.. It may not mention Afrezza in this article.. but we now know Coner uses Afrezza and it sounds like he is going to share his story ... This sounds amazing to me.. guess we will have to wait and see what happens. 🙂 .. Sure has been a lot of buzz around this stock lately.... |
|
